{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T05:39:07Z","timestamp":1794289147215,"version":"4.9.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100013771","name":"Discipline and Specialty, and Construction Foundation of Colleges and Universities of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nutr"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00394-025-03676-z","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T16:27:12Z","timestamp":1745857632000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of curcumin supplementation for the treatment and prevention of pouchitis after ileal pouch-anal anastomosis: a randomized controlled trial"],"prefix":"10.1007","volume":"64","author":[{"given":"An-qi","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-yi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-song","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-xiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8037-0850","authenticated-orcid":false,"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"3676_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/bmj.2.6130.85","volume":"2","author":"AG Parks","year":"1978","unstructured":"Parks AG, Nicholls RJ (1978) Proctocolectomy without ileostomy for ulcerative colitis. Br Med J 2:85\u201388","journal-title":"Br Med J"},{"key":"3676_CR2","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","volume":"11","author":"F Magro","year":"2017","unstructured":"Magro F, Gionchetti P, Eliakim R et al (2017) Third european evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Col 11:649\u2013670","journal-title":"J Crohns Col"},{"key":"3676_CR3","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/S0016-5085(03)00325-1","volume":"124","author":"U Mahadevan","year":"2003","unstructured":"Mahadevan U, Sandborn WJ (2003) Diagnosis and management of pouchitis. Gastroenterology 124:1636\u20131650","journal-title":"Gastroenterology"},{"key":"3676_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S2468-1253(21)00214-4","volume":"7","author":"B Shen","year":"2022","unstructured":"Shen B, Kochhar GS, Rubin DT et al (2022) Treatment of pouchitis, Crohn\u2019s disease, cuffitis, and other inflammatory disorders of the pouch: Consensus guidelines from the international ileal pouch consortium. Lancet Gastroenterol Hepatol 7:69\u201395","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3676_CR5","doi-asserted-by":"publisher","first-page":"175628482110233","DOI":"10.1177\/17562848211023376","volume":"14","author":"W Rabbenou","year":"2021","unstructured":"Rabbenou W, Chang S (2021) Medical treatment of pouchitis: a guide for the clinician. Therap Adv Gastroenterol 14:17562848211023376","journal-title":"Therap Adv Gastroenterol"},{"key":"3676_CR6","doi-asserted-by":"publisher","first-page":"21127","DOI":"10.3390\/molecules191221127","volume":"19","author":"BL Vecchi","year":"2014","unstructured":"Vecchi BL, Marcuzzi A, Tricarico PM et al (2014) Curcumin and inflammatory bowel disease: Potential and limits of innovative treatments. Molecules 19:21127\u201321153","journal-title":"Molecules"},{"key":"3676_CR7","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.drudis.2013.04.009","volume":"18","author":"V Soetikno","year":"2013","unstructured":"Soetikno V, Suzuki K, Veeraveedu PT et al (2013) Molecular understanding of curcumin in diabetic nephropathy. Drug Discov Today 18:756\u2013763","journal-title":"Drug Discov Today"},{"key":"3676_CR8","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/ptr.6581","volume":"34","author":"N Sadeghi","year":"2020","unstructured":"Sadeghi N, Mansoori A, Shayesteh A, Hashemi SJ (2020) The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis. Phytother Res 34:1123\u20131133","journal-title":"Phytother Res"},{"key":"3676_CR9","doi-asserted-by":"publisher","first-page":"9552","DOI":"10.1002\/jcb.27273","volume":"119","author":"M Masoodi","year":"2018","unstructured":"Masoodi M, Mahdiabadi MA, Mokhtare M et al (2018) The efficacy of curcuminoids in improvement of ulcerative colitis symptoms and patients\u2019 self-reported well-being: a randomized double-blind controlled trial. J Cell Biochem 119:9552\u20139559","journal-title":"J Cell Biochem"},{"key":"3676_CR10","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.cgh.2015.02.019","volume":"13","author":"A Lang","year":"2015","unstructured":"Lang A, Salomon N, Wu JC et al (2015) Curcumin in combination with mesalamine induces remission in patients with mild-to-moderate ulcerative colitis in a randomized controlled trial. Clin Gastroenterol Hepatol 13:1444\u20139.e1","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3676_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.crohns.2013.08.006","volume":"8","author":"V Singla","year":"2014","unstructured":"Singla V, Pratap MV, Garg SK et al (2014) Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis-a randomized, placebo-controlled, pilot study. J Crohns Colitis 8:208\u2013214","journal-title":"J Crohns Colitis"},{"key":"3676_CR12","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/MCG.0000000000001416","volume":"55","author":"R Banerjee","year":"2021","unstructured":"Banerjee R, Pal P, Penmetsa A et al (2021) Novel bioenhanced curcumin with mesalamine for induction of clinical and endoscopic remission in Mild-to-Moderate ulcerative colitis: a randomized double-blind placebo-controlled pilot study. J Clin Gastroenterol 55:702\u2013708","journal-title":"J Clin Gastroenterol"},{"key":"3676_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0025-6196(12)61634-6","volume":"69","author":"WJ Sandborn","year":"1994","unstructured":"Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF (1994) Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc 69:409\u2013415","journal-title":"Mayo Clin Proc"},{"key":"3676_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.11.006","author":"B Shen","year":"2008","unstructured":"Shen B, Remzi FH, Lavery IC, Lashner BA, Fazio VW (2008) A proposed classification of ileal pouch disorders and associated complications after restorative proctocolectomy. Clin Gastroenterol Hepatol. https:\/\/doi.org\/10.1016\/j.cgh.2007.11.006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"3676_CR15","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.cgh.2015.02.019","volume":"13","author":"A Lang","year":"2015","unstructured":"Lang A, Salomon N, Wu JC et al (2015) Curcumin in combination with mesalamine induces remission in patients with mild-to-moderate ulcerative colitis in a randomized controlled trial. Clin Gastroenterol Hepatol 13(8):1444\u20139.e1","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3676_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.explore.2024.103083","author":"Z Peng","year":"2024","unstructured":"Peng Z, Li D, Wu N et al (2024) Safety and efficacy of curcumin in the treatment of ulcerative colitis: an updated systematic review and meta-analysis of randomized controlled trials. Explore (NY). https:\/\/doi.org\/10.1016\/j.explore.2024.103083","journal-title":"Explore (NY)"},{"issue":"10","key":"3676_CR17","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1007\/s10620-018-5199-9","volume":"63","author":"J Athayde","year":"2018","unstructured":"Athayde J, Davies SC, Parker CE et al (2018) Placebo rates in randomized controlled trials of pouchitis therapy. Dig Dis Sci 63(10):2519\u20132528","journal-title":"Dig Dis Sci"},{"issue":"2","key":"3676_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1053\/gast.2000.9370","volume":"119","author":"P Gionchetti","year":"2000","unstructured":"Gionchetti P, Rizzello F, Venturi A et al (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119(2):305\u2013309","journal-title":"Gastroenterology"},{"key":"3676_CR19","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s10350-004-6652-8","volume":"46","author":"B Shen","year":"2003","unstructured":"Shen B, Achkar JP, Connor JT et al (2003) Modified pouchitis disease activity index: a simplified approach to the diagnosis of pouchitis. Dis Colon Rectum 46:748\u2013753","journal-title":"Dis Colon Rectum"},{"key":"3676_CR20","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1046\/j.1365-2036.2002.01203.x","volume":"16","author":"T Mimura","year":"2002","unstructured":"Mimura T, Rizzello F, Helwig U et al (2002) Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther 16:909\u2013917","journal-title":"Aliment Pharmacol Ther"},{"key":"3676_CR21","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1111\/j.1365-2036.2007.03306.x","volume":"25","author":"P Gionchetti","year":"2007","unstructured":"Gionchetti P, Rizzello F, Poggioli G et al (2007) Oral budesonide in the treatment of chronic refractory pouchitis. Aliment Pharmacol Ther 25:1231\u20131236","journal-title":"Aliment Pharmacol Ther"},{"key":"3676_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.crohns.2013.12.001","volume":"8","author":"P Gionchetti","year":"2014","unstructured":"Gionchetti P, Calabrese C, Calafiore A et al (2014) Oral beclomethasone dipropionate in chronic refractory pouchitis. J Crohns Colitis 8:649\u2013653","journal-title":"J Crohns Colitis"},{"key":"3676_CR23","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S0016-5085(89)80080-0","volume":"96","author":"G Guyatt","year":"1989","unstructured":"Guyatt G, Mitchell A, Irvine EJ et al (1989) A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 96:804\u2013810","journal-title":"Gastroenterology"},{"issue":"10","key":"3676_CR24","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1136\/gut.32.10.1166","volume":"32","author":"HJ de Silva","year":"1991","unstructured":"de Silva HJ, Millard PR, Soper N et al (1991) Effects of the faecal stream and stasis on the ileal pouch mucosa. Gut 32(10):1166\u20131169","journal-title":"Gut"},{"issue":"1","key":"3676_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/gut.32.1.61","volume":"32","author":"HJ de Silva","year":"1991","unstructured":"de Silva HJ, Millard PR, Kettlewell M et al (1991) Mucosal characteristics of pelvic ileal pouches. Gut 32(1):61\u201365","journal-title":"Gut"},{"issue":"6","key":"3676_CR26","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1136\/gut.22.6.462","volume":"22","author":"RJ Nicholls","year":"1981","unstructured":"Nicholls RJ, Belliveau P, Neill M et al (1981) Restorative proctocolectomy with ileal reservoir: a pathophysiological assessment. Gut 22(6):462\u2013468","journal-title":"Gut"},{"issue":"2","key":"3676_CR27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1136\/gut.35.2.243","volume":"35","author":"P Luukkonen","year":"1994","unstructured":"Luukkonen P, Jarvinen H, Tanskanen M et al (1994) Pouchitis\u2013recurrence of the inflammatory bowel disease? Gut 35(2):243\u2013246","journal-title":"Gut"},{"issue":"2","key":"3676_CR28","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S1091-255X(02)00191-9","volume":"7","author":"AB Fruin","year":"2003","unstructured":"Fruin AB, El-Zammer O, Stucchi AF et al (2003) Colonic metaplasia in the ileal pouch is associated with inflammation and is not the result of longterm adaptation. J Gastrointest Surg 7(2):246\u2013253","journal-title":"J Gastrointest Surg"},{"issue":"24","key":"3676_CR29","doi-asserted-by":"publisher","first-page":"813","DOI":"10.5694\/j.1326-5377.1977.tb99311.x","volume":"2","author":"SK Sutherland","year":"1977","unstructured":"Sutherland SK (1977) Antivenoms: better late than never. Med J Aust 2(24):813","journal-title":"Med J Aust"},{"issue":"12","key":"3676_CR30","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1136\/gut.35.12.1721","volume":"35","author":"CP Setti","year":"1994","unstructured":"Setti CP, Talbot IC, Nicholls RJ (1994) Longterm appraisal of the histological appearances of the ileal reservoir mucosa after restorative proctocolectomy for ulcerative colitis. Gut 35(12):1721\u20131727","journal-title":"Gut"},{"issue":"1","key":"3676_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1574-6968.2009.01514.x","volume":"294","author":"P Louis","year":"2009","unstructured":"Louis P, Flint HJ (2009) Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 294(1):1\u20138","journal-title":"FEMS Microbiol Lett"},{"issue":"6","key":"3676_CR32","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1463-1318.2005.00833.x","volume":"7","author":"FM Smith","year":"2005","unstructured":"Smith FM, Coffey JC, Kell MR et al (2005) A characterization of anaerobic colonization and associated mucosal adaptations in the undiseased ileal pouch. Colorectal Dis 7(6):563\u2013570","journal-title":"Colorectal Dis"},{"issue":"8","key":"3676_CR33","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/apt.13780","volume":"44","author":"KM Schieffer","year":"2016","unstructured":"Schieffer KM, Williams ED, Yochum GS et al (2016) Review article: the pathogenesis of pouchitis. Aliment Pharmacol Ther 44(8):817\u2013835","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"3676_CR34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/SLA.0b013e3181e3dc8b","volume":"252","author":"SD Mclaughlin","year":"2010","unstructured":"Mclaughlin SD, Walker AW, Churcher C et al (2010) The bacteriology of pouchitis: a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencing. Ann Surg 252(1):90\u201398","journal-title":"Ann Surg"},{"issue":"2","key":"3676_CR35","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1128\/jcm.30.2.312-317.1992","volume":"30","author":"AB Onderdonk","year":"1992","unstructured":"Onderdonk AB, Dvorak AM, Cisneros RL et al (1992) Microbiologic assessment of tissue biopsy samples from ileal pouch patients. J Clin Microbiol 30(2):312\u2013317","journal-title":"J Clin Microbiol"},{"key":"3676_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13059-015-0637-x","volume":"16","author":"XC Morgan","year":"2015","unstructured":"Morgan XC, Kabakchiev B, Waldron L et al (2015) Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease. Genome Biol 16:67","journal-title":"Genome Biol"},{"issue":"10","key":"3676_CR37","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1136\/jcp.43.10.824","volume":"43","author":"HJ de Silva","year":"1990","unstructured":"de Silva HJ, Gatter KC, Millard PR et al (1990) Crypt cell proliferation and HLA-DR expression in pelvic ileal pouches. J Clin Pathol 43(10):824\u2013828","journal-title":"J Clin Pathol"},{"issue":"5","key":"3676_CR38","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1136\/gut.35.5.658","volume":"35","author":"EJ Ruseler-Van","year":"1994","unstructured":"Ruseler-Van EJ, Schouten WR, van Lieshout LM (1994) Pouchitis: result of microbial imbalance? Gut 35(5):658\u2013664","journal-title":"Gut"},{"issue":"8","key":"3676_CR39","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1007\/DCR.0b013e3181a7b77a","volume":"52","author":"M Lim","year":"2009","unstructured":"Lim M, Adams JD, Wilcox M et al (2009) An assessment of bacterial dysbiosis in pouchitis using terminal restriction fragment length polymorphisms of 16S ribosomal DNA from pouch effluent microbiota. Dis Colon Rectum 52(8):1492\u20131500","journal-title":"Dis Colon Rectum"},{"issue":"9","key":"3676_CR40","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1111\/apt.16096","volume":"52","author":"C Caenepeel","year":"2020","unstructured":"Caenepeel C, Sadat STN, Vieira-silva S et al (2020) Review article: how the intestinal microbiota may reflect disease activity and influence therapeutic outcome in inflammatory bowel disease. Aliment Pharmacol Ther 52(9):1453\u20131468","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"3676_CR41","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s00535-009-0191-y","volume":"45","author":"R Hansen","year":"2010","unstructured":"Hansen R, Thomson JM, El-omar EM et al (2010) The role of infection in the aetiology of inflammatory bowel disease. J Gastroenterol 45(3):266\u2013276","journal-title":"J Gastroenterol"},{"issue":"7285","key":"3676_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","volume":"464","author":"J Qin","year":"2010","unstructured":"Qin J, Li R, Raes J et al (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285):59\u201365","journal-title":"Nature"},{"issue":"11","key":"3676_CR43","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1038\/ajg.2010.281","volume":"105","author":"CW Png","year":"2010","unstructured":"Png CW, Linden SK, Gilshenan KS et al (2010) Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 105(11):2420\u20132428","journal-title":"Am J Gastroenterol"},{"key":"3676_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aao1605","author":"L Zhou","year":"2018","unstructured":"Zhou L, Sonnenberg GF (2018) Essential immunologic orchestrators of intestinal homeostasis. Sci Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.aao1605","journal-title":"Sci Immunol"},{"issue":"7692","key":"3676_CR45","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature25500","volume":"554","author":"M Xu","year":"2018","unstructured":"Xu M, Pokrovskii M, Ding Y et al (2018) c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont. Nature 554(7692):373\u2013377","journal-title":"Nature"},{"issue":"1","key":"3676_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00281-014-0454-4","volume":"37","author":"K Matsuoka","year":"2015","unstructured":"Matsuoka K, Kanai T (2015) The gut microbiota and inflammatory bowel disease. Semin Immunopathol 37(1):47\u201355","journal-title":"Semin Immunopathol"},{"issue":"1","key":"3676_CR47","doi-asserted-by":"publisher","first-page":"1802209","DOI":"10.1080\/19490976.2020.1802209","volume":"12","author":"H Gamage","year":"2020","unstructured":"Gamage H, Chong R, Bucio-Noble D et al (2020) Changes in dietary fiber intake in mice reveal associations between colonic mucin O-glycosylation and specific gut bacteria. Gut Microbes 12(1):1802209","journal-title":"Gut Microbes"},{"key":"3676_CR48","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1097\/DCR.0b013e31829ebd83","volume":"56","author":"M Uchino","year":"2013","unstructured":"Uchino M, Ikeuchi H, Matsuoka H et al (2013) Topical tacrolimus therapy for antibiotic-refractory pouchitis. Dis Colon Rectum 56:1166\u20131173","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"3676_CR49","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1080\/00365521.2019.1569718","volume":"54","author":"MD Kjaer","year":"2019","unstructured":"Kjaer MD, Qvist N, Nordgaard-Lassen I, Christensen LA, Kjeldsen J (2019) Adalimumab in the treatment of chronic pouchitis. A randomized double-blind placebo-controlled trial. Scand J Gastroenterol 54(1):188\u2013193","journal-title":"Scand J Gastroenterol"},{"key":"3676_CR50","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/ibd\/izx049","volume":"24","author":"M Huguet","year":"2018","unstructured":"Huguet M, Pereira B, Goutte M et al (2018) Systematic review with meta-analysis: anti-TNF therapy in refractory pouchitis and crohn\u2019s disease-like complications of the pouch after ileal pouch-anal anastomosis following colectomy for ulcerative colitis. Inflamm Bowel Dis 24:261\u2013268","journal-title":"Inflamm Bowel Dis"},{"key":"3676_CR51","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/MCG.0000000000001550","volume":"55","author":"S Chandan","year":"2021","unstructured":"Chandan S, Mohan BP, Kumar A et al (2021) Safety and efficacy of biological therapy in chronic antibiotic refractory pouchitis: a systematic review with meta-analysis. J Clin Gastroenterol 55:481\u2013491","journal-title":"J Clin Gastroenterol"},{"key":"3676_CR52","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1177\/2050640619871797","volume":"7","author":"B Verstockt","year":"2019","unstructured":"Verstockt B, Claeys C, De Hertogh G et al (2019) Outcome of biological therapies in chronic antibiotic-refractory pouchitis: a retrospective single-centre experience. United European Gastroenterol J 7:1215\u20131225","journal-title":"United European Gastroenterol J"},{"key":"3676_CR53","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/ibd\/izy302","volume":"25","author":"KN Weaver","year":"2019","unstructured":"Weaver KN, Gregory M, Syal G et al (2019) Ustekinumab is effective for the treatment of crohn\u2019s disease of the pouch in a multicenter cohort. Inflamm Bowel Dis 25:767\u2013774","journal-title":"Inflamm Bowel Dis"},{"key":"3676_CR54","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1007\/s10620-019-05697-1","volume":"64","author":"JE Ollech","year":"2019","unstructured":"Ollech JE, Rubin DT, Glick L et al (2019) Ustekinumab is effective for the treatment of chronic Antibiotic-Refractory pouchitis. Dig Dis Sci 64:3596\u20133601","journal-title":"Dig Dis Sci"},{"key":"3676_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001176.pub5","author":"N Nguyen","year":"2019","unstructured":"Nguyen N, Zhang B, Holubar SD, Pardi DS, Singh S (2019) Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD001176.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"3676_CR56","doi-asserted-by":"publisher","first-page":"9183","DOI":"10.3390\/molecules20059183","volume":"20","author":"Y He","year":"2015","unstructured":"He Y, Yue Y, Zheng X et al (2015) Curcumin, inflammation, and chronic diseases: How are they linked? Molecules 20:9183\u20139213","journal-title":"Molecules"},{"key":"3676_CR57","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/ibd.21391","volume":"17","author":"CB Larmonier","year":"2011","unstructured":"Larmonier CB, Midura-Kiela MT, Ramalingam R et al (2011) Modulation of neutrophil motility by curcumin: Implications for inflammatory bowel disease. Inflamm Bowel Dis 17:503\u2013515","journal-title":"Inflamm Bowel Dis"},{"key":"3676_CR58","doi-asserted-by":"publisher","first-page":"G85","DOI":"10.1152\/ajpgi.00275.2011","volume":"302","author":"MT Midura-Kiela","year":"2012","unstructured":"Midura-Kiela MT, Radhakrishnan VM, Larmonier CB et al (2012) Curcumin inhibits interferon-gamma signaling in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 302:G85-96","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3676_CR59","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.intimp.2011.10.010","volume":"12","author":"S Mouzaoui","year":"2012","unstructured":"Mouzaoui S, Rahim I, Djerdjouri B (2012) Aminoguanidine and curcumin attenuated tumor necrosis factor (TNF)-alpha-induced oxidative stress, colitis and hepatotoxicity in mice. Int Immunopharmacol 12:302\u2013311","journal-title":"Int Immunopharmacol"},{"key":"3676_CR60","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1089\/jmf.2012.2550","volume":"16","author":"Y Topcu-Tarladacalisir","year":"2013","unstructured":"Topcu-Tarladacalisir Y, Akpolat M, Uz YH et al (2013) Effects of curcumin on apoptosis and oxidoinflammatory regulation in a rat model of acetic acid-induced colitis: The roles of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase. J Med Food 16:296\u2013305","journal-title":"J Med Food"},{"issue":"7","key":"3676_CR61","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.bcp.2003.12.024","volume":"67","author":"AR Martin","year":"2004","unstructured":"Martin AR, Villegas I, La Casa C et al (2004) Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats. Biochem Pharmacol 67(7):1399\u20131410","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"3676_CR62","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/ibd.21391","volume":"17","author":"CB Larmonier","year":"2011","unstructured":"Larmonier CB, Midura-Kiela MT, Ramalingam R et al (2011) Modulation of neutrophil motility by curcumin: implications for inflammatory bowel disease. Inflamm Bowel Dis 17(2):503\u2013515","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"3676_CR63","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1152\/ajpgi.90365.2008","volume":"295","author":"CB Larmonier","year":"2008","unstructured":"Larmonier CB, Uno JK, Lee KM et al (2008) Limited effects of dietary curcumin on Th-1 driven colitis in IL-10 deficient mice suggest an IL-10-dependent mechanism of protection. Am J Physiol Gastrointest Liver Physiol 295(5):1079\u20131091","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"3676_CR64","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ibd.20348","volume":"14","author":"C Billerey-Larmonier","year":"2008","unstructured":"Billerey-Larmonier C, Uno JK, Larmonier N et al (2008) Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent. Inflamm Bowel Dis 14(6):780\u2013793","journal-title":"Inflamm Bowel Dis"},{"issue":"24","key":"3676_CR65","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.3748\/wjg.v12.i24.3848","volume":"12","author":"H Jiang","year":"2006","unstructured":"Jiang H, Deng CS, Zhang M et al (2006) Curcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2. World J Gastroenterol 12(24):3848\u20133853","journal-title":"World J Gastroenterol"},{"issue":"3","key":"3676_CR66","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.intimp.2006.11.006","volume":"7","author":"L Camacho-Barquero","year":"2007","unstructured":"Camacho-Barquero L, Villegas I, Sanchez-calvo JM et al (2007) Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Int Immunopharmacol 7(3):333\u2013342","journal-title":"Int Immunopharmacol"},{"issue":"3\u20134","key":"3676_CR67","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/BF01967418","volume":"28","author":"R Srivastava","year":"1989","unstructured":"Srivastava R (1989) Inhibition of neutrophil response by curcumin. Agents Actions 28(3\u20134):298\u2013303","journal-title":"Agents Actions"},{"issue":"11","key":"3676_CR68","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1002\/eji.200939052","volume":"39","author":"Y Cong","year":"2009","unstructured":"Cong Y, Wang L, Konrad A et al (2009) Curcumin induces the tolerogenic dendritic cell that promotes differentiation of intestine-protective regulatory T cells. Eur J Immunol 39(11):3134\u20133146","journal-title":"Eur J Immunol"},{"issue":"1","key":"3676_CR69","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10875-006-9066-7","volume":"27","author":"GC Jagetia","year":"2007","unstructured":"Jagetia GC, Aggarwal BB (2007) \u201cSpicing up\u201d of the immune system by curcumin. J Clin Immunol 27(1):19\u201335","journal-title":"J Clin Immunol"},{"issue":"1","key":"3676_CR70","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bcp.2004.03.015","volume":"68","author":"X Gao","year":"2004","unstructured":"Gao X, Kuo J, Jiang H et al (2004) Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. Biochem Pharmacol 68(1):51\u201361","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"3676_CR71","first-page":"823","volume":"150","author":"P Parronchi","year":"1997","unstructured":"Parronchi P, Romagnani P, Annunziato F et al (1997) Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn\u2019s disease. Am J Pathol 150(3):823\u2013832","journal-title":"Am J Pathol"},{"issue":"8","key":"3676_CR72","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/j.1745-7254.2006.00322.x","volume":"27","author":"M Zhang","year":"2006","unstructured":"Zhang M, Deng CS, Zheng JJ et al (2006) Curcumin regulated shift from Th1 to Th2 in trinitrobenzene sulphonic acid-induced chronic colitis. Acta Pharmacol Sin 27(8):1071\u20131077","journal-title":"Acta Pharmacol Sin"},{"issue":"8","key":"3676_CR73","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1093\/jac\/dks132","volume":"67","author":"PN Mimche","year":"2012","unstructured":"Mimche PN, Thompson E, Taramelli D et al (2012) Curcumin enhances non-opsonic phagocytosis of Plasmodium falciparum through up-regulation of CD36 surface expression on monocytes\/macrophages. J Antimicrob Chemother 67(8):1895\u20131904","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"3676_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012969","volume":"5","author":"WB Song","year":"2010","unstructured":"Song WB, Wang YY, Meng FS et al (2010) Curcumin protects intestinal mucosal barrier function of rat enteritis via activation of MKP-1 and attenuation of p38 and NF-kappaB activation. PLoS ONE 5(9):e12969","journal-title":"PLoS ONE"},{"issue":"12","key":"3676_CR75","doi-asserted-by":"publisher","first-page":"8116","DOI":"10.4049\/jimmunol.174.12.8116","volume":"174","author":"GY Kim","year":"2005","unstructured":"Kim GY, Kim KH, Lee SH et al (2005) Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets. J Immunol 174(12):8116\u20138124","journal-title":"J Immunol"},{"issue":"7","key":"3676_CR76","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1248\/bpb.29.1470","volume":"29","author":"DO Moon","year":"2006","unstructured":"Moon DO, Jin CY, Lee JD et al (2006) Curcumin decreases binding of Shigalike toxin-1B on human intestinal epithelial cell line HT29 stimulated with TNF-alpha and IL-1beta: suppression of p38, JNK and NF-kappaB p65 as potential targets. Biol Pharm Bull 29(7):1470\u20131475","journal-title":"Biol Pharm Bull"},{"issue":"11","key":"3676_CR77","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1902\/jop.2016.150722","volume":"87","author":"B Bakir","year":"2016","unstructured":"Bakir B, Yetkin AZ, Buyukbayram HI et al (2016) Effect of curcumin on systemic T helper 17 cell response; gingival expressions of interleukin17 and retinoic acid receptor-related orphan receptor gammat; and alveolar bone loss in experimental periodontitis. J Periodontol 87(11):183\u2013191","journal-title":"J Periodontol"},{"issue":"4","key":"3676_CR78","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1128\/AAC.01242-08","volume":"53","author":"R De","year":"2009","unstructured":"De R, Kundu P, Swarnakar S et al (2009) Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob Agents Chemother 53(4):1592\u20131597","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"3676_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185999","volume":"12","author":"M Ohno","year":"2017","unstructured":"Ohno M, Nishida A, Sugitani Y et al (2017) Nanoparticle curcumin ameliorates experimental colitis via modulation of gut microbiota and induction of regulatory T cells. PLoS ONE 12(10):e185999","journal-title":"PLoS ONE"},{"issue":"3","key":"3676_CR80","doi-asserted-by":"publisher","first-page":"333","DOI":"10.4161\/gmic.28572","volume":"5","author":"S Narushima","year":"2014","unstructured":"Narushima S, Sugiura Y, Oshima K et al (2014) Characterization of the 17 strains of regulatory T cell-inducing human-derived Clostridia. Gut Microbes 5(3):333\u2013339","journal-title":"Gut Microbes"},{"issue":"7","key":"3676_CR81","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1136\/gutjnl-2014-307329","volume":"64","author":"IK Law","year":"2015","unstructured":"Law IK, Bakirtzi K, Polytarchou C et al (2015) Neurotensin\u2013regulated miR-133alpha is involved in proinflammatory signalling in human colonic epithelial cells and in experimental colitis. Gut 64(7):1095\u20131104","journal-title":"Gut"},{"issue":"33","key":"3676_CR82","doi-asserted-by":"publisher","first-page":"14691","DOI":"10.1073\/pnas.1005963107","volume":"107","author":"C De Filippo","year":"2010","unstructured":"De Filippo C, Cavalieri D, Di Paola M et al (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 107(33):14691\u201314696","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7268","key":"3676_CR83","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/nature08530","volume":"461","author":"KM Maslowski","year":"2009","unstructured":"Maslowski KM, Vieira AT, Ng A et al (2009) Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461(7268):1282\u20131286","journal-title":"Nature"},{"key":"3676_CR84","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4292\/wjgpt.v8.i2.147","volume":"8","author":"S Kedia","year":"2017","unstructured":"Kedia S, Bhatia V, Thareja S et al (2017) Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: results from a randomized double blind placebo controlled trial. World J Gastrointest Pharmacol Ther 8:147\u2013154","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"3676_CR85","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.cgh.2006.08.008","volume":"4","author":"H Hanai","year":"2006","unstructured":"Hanai H, Iida T, Takeuchi K et al (2006) Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 4:1502\u20131506","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3676_CR86","doi-asserted-by":"publisher","first-page":"175628482097120","DOI":"10.1177\/1756284820971201","volume":"13","author":"RTJ Maria","year":"2020","unstructured":"Maria RTJ, Coss AE, Angel VDM et al (2020) Lactobacillus acidophilus LB: a useful pharmabiotic for the treatment of digestive disorders. Therap Adv Gastroenterol 13:1756284820971201","journal-title":"Therap Adv Gastroenterol"},{"key":"3676_CR87","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/208064","volume":"2014","author":"B Tomasz","year":"2014","unstructured":"Tomasz B, Zoran S, Jaroslaw W et al (2014) Long-term use of probiotics Lactobacillus and Bifidobacterium has a prophylactic effect on the occurrence and severity of pouchitis: a randomized prospective study. Biomed Res Int 2014:208064","journal-title":"Biomed Res Int"},{"key":"3676_CR88","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/S0016-5085(03)00171-9","volume":"124","author":"P Gionchetti","year":"2003","unstructured":"Gionchetti P, Rizzello F, Helwig U et al (2003) Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124:1202\u20131209","journal-title":"Gastroenterology"},{"key":"3676_CR89","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/gut.53.1.108","volume":"53","author":"T Mimura","year":"2004","unstructured":"Mimura T, Rizzello F, Helwig U et al (2004) Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53:108\u2013114","journal-title":"Gut"},{"key":"3676_CR90","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.3748\/wjg.v23.i26.4735","volume":"23","author":"YY Xu","year":"2017","unstructured":"Xu YY, Zhang YY, He AQ et al (2017) Lactobacillus acidophilus alleviates pouchitis after ileal pouch-anal anastomosis in rats. World J Gastroenterol 23:4735\u20134743","journal-title":"World J Gastroenterol"},{"key":"3676_CR91","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1046\/j.1365-2036.2003.01465.x","volume":"17","author":"J Kuisma","year":"2003","unstructured":"Kuisma J, Mentula S, Jarvinen H et al (2003) Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. Aliment Pharmacol Ther 17:509\u2013515","journal-title":"Aliment Pharmacol Ther"},{"key":"3676_CR92","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cgh.2013.09.027","volume":"12","author":"O Ben-Bassat","year":"2014","unstructured":"Ben-Bassat O, Tyler AD, Xu W et al (2014) Ileal pouch symptoms do not correlate with inflammation of the pouch. Clin Gastroenterol Hepatol 12:831-837.e2","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3676_CR93","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/ecco-jcc\/jjab125","volume":"16","author":"ZS Ardalan","year":"2022","unstructured":"Ardalan ZS, Friedman AB, Con D et al (2022) Accuracy of gastrointestinal ultrasound and calprotectin in the assessment of inflammation and its location in patients with an ileoanal pouch. J Crohns Colitis 16:79\u201390","journal-title":"J Crohns Colitis"},{"key":"3676_CR94","doi-asserted-by":"publisher","first-page":"3467419","DOI":"10.1155\/2020\/3467419","volume":"2020","author":"YH Chen","year":"2020","unstructured":"Chen YH, Wang L, Feng SY et al (2020) The relationship between C-reactive protein\/albumin ratio and disease activity in patients with inflammatory bowel disease. Gastroenterol Res Pract 2020:3467419","journal-title":"Gastroenterol Res Pract"},{"key":"3676_CR95","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12876-022-02113-3","volume":"22","author":"S Furukawa","year":"2022","unstructured":"Furukawa S, Yagi S, Shiraishi K et al (2022) Effect of disease duration on the association between C-reactive protein-albumin ratio and endoscopic activity in ulcerative colitis. Bmc Gastroenterol 22:39","journal-title":"Bmc Gastroenterol"}],"container-title":["European Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-025-03676-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00394-025-03676-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-025-03676-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T13:02:24Z","timestamp":1749733344000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00394-025-03676-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":95,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3676"],"URL":"https:\/\/doi.org\/10.1007\/s00394-025-03676-z","relation":{},"ISSN":["1436-6207","1436-6215"],"issn-type":[{"value":"1436-6207","type":"print"},{"value":"1436-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"29 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The study was performed in accordance with the Declaration of Helsinki and was approved by the ethics committee of our hospital. Written, informed consent was obtained from all recruited patients. This study was registered in the China Clinical Trial Registry Center (clinical trial registration number: ChiCTR1900022243). This study was also approved by the Medical Institution\u2019s Ethics Committee (approval number: IRB2019-225\u201301). All authors had access to the study data and reviewed and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All the authors approved the publication of the article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study was registered in the China Clinical Trial Registry Center (clinical trial registration number: ChiCTR1900022243). This study was also approved by the Medical Institution\u2019s Ethics Committee (approval number: IRB2019-225\u201301).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trials Registration"}}],"article-number":"167"}}